Literature DB >> 30988757

Electrospun gelatin/PCL and collagen/PCL scaffolds for modulating responses of bone marrow endothelial progenitor cells.

Yang Hu1,2, Bei Feng3, Weijie Zhang1,2, Chenxi Yan1,2, Qinke Yao1,2, Chunyi Shao1,2, Fei Yu1,2, Fen Li3, Yao Fu1,2.   

Abstract

The determination of potential transplantable substrates and substitution cells for corneal endothelium transplantation may compensate for the shortage of cornea donors. Appropriate biodegradable and biocompatible tissue-engineered substratum with seed cells for endothelial keratoplasty has been increasingly studied. In the present study, electrospun gelatin/polycaprolactone (PCL) and collagen/PCL scaffolds were successfully established. Bone marrow endothelial progenitor cells (BEPCs) were cultured on these scaffolds to determine whether the scaffolds may promote the proliferation of BEPCs as well as maintain stem cell characteristics. Two variations of hybrid scaffolds, collagen/PCL (70% collagen and 30% PCL) and gelatin/PCL (70% gelatin and 30% PCL), were established via electrospinning. Microscopic structure, hydrophilicity and wettability of the two scaffolds were subsequently investigated. BEPCs were separately cultured on the scaffolds and were also seeded on glass slides to establish the control group. Furthermore, cell morphology; adherence, as determined by investigation of F-actin expression levels; proliferation, as determined via Cell Counting Kit-8 assays, Ki-67 staining and bromodeoxyuridine (BrdU) staining; and stem cell markers, as determined by cluster of differentiation (CD)-34 and CD-133 protein expression levels; were investigated. In addition, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed to determine gene expression. The two nanofiber scaffolds were established using electrospun techniques with expected hydrophilicity, wettability and biocompatibility. BEPCs were revealed to spread well on and strongly adhere to the collagen/PCL (70:30) and gelatin/PCL (70:30) scaffolds. Furthermore, Ki-67 and BrdU staining results revealed greater levels of positive dots on the two hybrid scaffolds compared with the control group. CD-34 and CD-133 protein staining demonstrated increased levels of fluorescence intensity on scaffolds compared with the control group. Furthermore, increased expression levels of differentiation markers, such as ATP binding cassette subfamily G member 2, leucine rich repeat containing G protein-coupled receptor 5 and CD166, were detected on both scaffolds. RT-qPCR results demonstrated that the expression of caspase-3, which is associated with apoptosis, was decreased on the two scaffolds compared with in the control group. The expression of inflammatory factors, including interleukin (IL)-1, exhibited a significant decrease on the gelatin/PCL scaffold compared with in the control group; whereas the difference between the expression level of IL-1 exhibited by the collagen/PCL group and the control group were not markedly different. Electrospun collagen/PCL and gelatin/PCL scaffolds exhibited the potential to enhance the adherence and proliferation of BEPCs. BEPCs cultured on the two scaffolds demonstrated increased stem cell characteristics and differentiation potential. Electrospun gelatin/PCL and collagen/PCL scaffolds may represent a promising substratum in tissue-engineered corneal endothelium.

Entities:  

Keywords:  bone marrow endothelial progenitor cell; collagen; corneal endothelium; electrospun nanofibrous membrane; gelatin; scaffolds

Year:  2019        PMID: 30988757      PMCID: PMC6447824          DOI: 10.3892/etm.2019.7387

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  8 in total

1.  Vitamin B12-loaded polycaprolacton/gelatin nanofibrous scaffold as potential wound care material.

Authors:  Sayeed Farzanfar; Gholamreza Savari Kouzekonan; Ruhollah Mirjani; Babak Shekarchi
Journal:  Biomed Eng Lett       Date:  2020-09-15

2.  In situ differentiation of human-induced pluripotent stem cells into functional cardiomyocytes on a coaxial PCL-gelatin nanofibrous scaffold.

Authors:  Divya Sridharan; Arunkumar Palaniappan; Britani N Blackstone; Julie A Dougherty; Naresh Kumar; Polani B Seshagiri; Nazish Sayed; Heather M Powell; Mahmood Khan
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-08-11       Impact factor: 7.328

3.  Incorporation of Fibrin Matrix into Electrospun Membranes for Periodontal Wound Healing.

Authors:  Choyi Wong; Suyog Yoganarasimha; Caroline Carrico; Parthasarathy Madurantakam
Journal:  Bioengineering (Basel)       Date:  2019-06-30

Review 4.  Nature-Derived and Synthetic Additives to poly(ɛ-Caprolactone) Nanofibrous Systems for Biomedicine; an Updated Overview.

Authors:  Shahin Homaeigohar; Aldo R Boccaccini
Journal:  Front Chem       Date:  2022-01-19       Impact factor: 5.221

5.  Development and Characterization of Furfuryl-Gelatin Electrospun Scaffolds for Cardiac Tissue Engineering.

Authors:  Naveen Nagiah; Raven El Khoury; Mahmoud H Othman; Jun Akimoto; Yoshihiro Ito; David A Roberson; Binata Joddar
Journal:  ACS Omega       Date:  2022-04-13

Review 6.  Recent Progress and Potential Biomedical Applications of Electrospun Nanofibers in Regeneration of Tissues and Organs.

Authors:  AbdElAziz A Nayl; Ahmed I Abd-Elhamid; Nasser S Awwad; Mohamed A Abdelgawad; Jinglei Wu; Xiumei Mo; Sobhi M Gomha; Ashraf A Aly; Stefan Bräse
Journal:  Polymers (Basel)       Date:  2022-04-07       Impact factor: 4.967

Review 7.  The Use of Polymer Blends in the Treatment of Ocular Diseases.

Authors:  Raquel Gregorio Arribada; Francine Behar-Cohen; Andre Luis Branco de Barros; Armando Silva-Cunha
Journal:  Pharmaceutics       Date:  2022-07-07       Impact factor: 6.525

8.  Poly-Alanine-ε-Caprolacton-Methacrylate as Scaffold Material with Tuneable Biomechanical Properties for Osteochondral Implants.

Authors:  Nicole Hauptmann; Johanna Ludolph; Holger Rothe; Jürgen Rost; Alexander Krupp; Jörg Lechner; Svenja Kohlhaas; Manuela Winkler; Benedikt Stender; Gerhard Hildebrand; Klaus Liefeith
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.